CClinicalTrials.gg
RecruitingNCT05705154Updated Sep 8, 2023

Connecting Breath and Mind for CYP With Long COVID

An interventional study of Psychology interventions in Post-COVID-19 Syndrome, Anxiety and Breathlessness, sponsored by Royal Brompton & Harefield NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-09-08.

Sponsored by Royal Brompton & Harefield NHS Foundation Trust · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2024, 2 years 6 months ago, but the record still lists the study as recruiting.
  • Started Apr 2023; still recruiting 3 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Study summary

Recruitment target: Phase I: Co-design of intervention: 5 to 15 CYP aged between 12-18 years of age referred to the pan-London long COVID MDT.

Phase II: Randomised pilot: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT.

Methods: Phase I: Co-design Design and setting The intervention will be co-designed with CYP following a process informed by practice-base evidence, which centres the voices and wisdom of CYP, focuses on creativity and playfulness, and systemic and narrative approaches. The process will involve: 1) Refining the intentions of key stakeholders (including ways of bringing psychological and physiological principles into the intervention); 2) Participation of CYP; 3) Creativity and playfulness and 4) Responding to feedback (see Salvo et al., 2022).

Phase II. Pilot Population: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT. CYP will be randomised to receive either standard treatment or standard treatment plus intervention.

Study Treatment Standard treatment consists of virtual MDT discussion with referrer and advice signposting into local services for specific issues. They are sent leaflets and information. If a patient is severely affected enough to be seen face to face, they are offered an interdisciplinary consultation, and tailored input from therapies and psychological services.

Access to bite size videos and leaflets covering the following topics: sleep, pacing, activity management, school reintegration, managing friendships, eating well and emotional wellbeing. Young people are invited to a single virtual group Q\&A session to bring any queries after watching the videos.

The leaflets and online sessions have been developed by professionals from the Evelina, Great Ormond Street Hospital, Imperial, University College London Hospital, and the Whittington. The bite size videos and live sessions are delivered by a clinical psychologist, a dietitian, specialist nurse, occupational therapist, and physiotherapist. More complex or severely affected patients will receive one to one treatment with members of the MDT as required.

Intervention

Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention.:

  • Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment
  • Identifying the connections between body and mind to address anxiety and breathlessness
  • Coping skills for managing anxiety using principles from narrative therapy and mindfulness
  • Online materials to improve self-efficacy with home practice
  • Social connection with other CYP for peer support, and resource sharing
  • Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems
Read the detailed description

Hypotheses: CYP with a diagnosis of Long COVID who complete the intervention in addition to standard treatment will show a greater improvement in psychological wellbeing and demonstrate fewer functional limitations of excessive breathlessness after completing a holistic modular psychological and respiratory physiotherapy (PT) intervention compared to current standard treatment alone.

Primary objective Impact score of Strength and Difficulties (SDQ) questionnaire (included in ISARIC form - standard care assessment).

-RCADS questionnaire (17), pre- and post-intervention.

Secondary Objectives

To further answer the Ho the following measures will be taken:

  • Improved dysfunctional breathing measured by multi-dimensional physiotherapy assessment of breathing pattern including Nijmegen questionnaire, breathing pattern category, SMART goal setting, lung function and cardiopulmonary exercise testing and specialist physiotherapist assessment of breathing pattern quality pre- and post-intervention.
  • At baseline and 6-monthly, all CYP will complete the standard assessment questionnaires for the long COVID pan-London pathway in line with the NHSE commissioning guidance which includes the following questionnaires to assess quality of life, psychological well-being, and adaptive functioning.

    • Revised Children's Anxiety and Depression Scale (RCADS) questionnaire (17), pre- and post-intervention.
    • EQ-5D-Y (25)
    • SF-36 Quality of life (26)
    • 11-item Chalder Fatigue Questionnaire (27) and
    • Visual analogue pain scale
    • FitBit Activity monitoring including daily step counts, daily distance travelled, daily stairs climbed, sedentary minutes, low, moderate and vigorous activity minutes, sleep hours, and wear time.

Secondary research question: Are co-designed virtual psychology and physiotherapy interventions acceptable and feasible to service users?

Quantitative data: participation, attendance and dropout rates will be collected. Technical issues with being able to access the intervention will be documented.

Qualitative feedback will be obtained to enable development of the intervention.

-The facilitators will gather live feedback towards the end of each group session using a range of approaches. As part of the focus groups the CYP will review the outcome measure to get feedback if these are the things that matter to them the most. Activities to explore outcomes that matter to CYP will be reviewed in the focus groups.

Qualitative feedback will also be obtained after completion of all the group sessions when the investigator administers the post-intervention measures. This will include measures of usefulness, willingness to recommend to a friend, and qualitative questions on experience of the group, best parts of the group, and suggestions for improvement.

The investigator will also assess the impact of prior mental health problems, severity of COVID infection (community acquired vs. hospitalised) and prior functioning on intervention response.

Study Design The project is a Pan-London research project recruiting patients from across London.

The objectives of this two-part research project are firstly to co-design a novel holistic group intervention with children and young people with long COVID. The intervention will be developed based on existing literature and interventions for psychological distress and for dysfunctional breathing in similar clinical cohorts, and from focus groups with CYP with long COVID and their parents/ caregivers to ensure acceptability and appropriateness.

The second phase of this project will be to prospectively pilot the new services to assess the efficacy, acceptability, and feasibility from both the service user and service providers. The intervention will be piloted in a cohort of CYP with long COVID as an adjunctive intervention to treatment as usual, assessing impact on well being and breathing outcomes.

Phase I. Co-design Method Design and setting The intervention will be co-designed with CYP following a process informed by practice-base evidence, which centres the voices and wisdom of CYP, focuses on creativity and playfulness, and systemic and narrative approaches. The process will involve: 1) Refining the intentions of key stakeholders (including ways of bringing psychological and physiological principles into the intervention); 2) Participation of CYP; 3) Creativity and playfulness and 4) Responding to feedback (see Salvo et al., 2022).

Participation of CYP will include:

  • The use of group interventions co-designed with CYP with other conditions such as diabetes, chronic pain, myalgic encephalomyelitis/chronic fatigue syndrome and medically unexplained conditions as examples to help CYP with long COVID consider some possibilities and enable them to develop their own ideas for the intervention.
  • Responding to feedback and recruitment of CYP 'advisors' (name and responsibilities included in the role to be agreed with CYP)
  • The use of focus groups guided by 4Pi framework and principles (NSUN, 2015) including openness and transparency about the process, finding ways to ensure the meaningful involvement of all CYP with long COVID, including those from black and minority ethnic communities, LGBTQ+ young people and other 'marginalised' groups to co-design and develop the intervention, consider recruitment and outcome measures.

The University College London Hospitals (UCLH) psychology team have developed a number of innovative and award-winning groups (20-24) that will be used as exemplars to help young people think what they might want to be included in the groups as well as delivery style (e.g., vlogs and podcasts versus leaflet), preferred frequency and length. Parents will also be invited to attend a focus group and invited to comment on similar questions. The investigators are planning to offer the groups for the CYP unaccompanied by parents.

  • As part of the focus groups the CYP will review the outcome measures to get feedback if these are the things that matter to them the most. Activities to explore outcomes that matter to CYP will be reviewed in the focus groups.

Each focus group session will be via zoom and be recorded. The recording will be downloaded to a secure encrypted hospital drive. The audio recording will be used to transcribe into a script. Once this script is checked the video and audio recordings can be deleted.

Co-design participants Service Users: The investigators aim to recruit 5 to 15 young people Inclusion: CYP aged between 12-18 years old who have been referred into the Pan-London Long COVID Multi-disciplinary Team (MDT) Clinic from its inception in 2020.

Exclusion: No objective evidence of SARS-CoV-2 infection e.g., positive PCR testing or antibodies. Significant neurodevelopmental difficulties (severe autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), global intellectual disability) and/or high psychiatric risk e.g., suicidality, severe emotional or behavioural dysregulation precluding participation in group intervention (PI screened during the MDT discussion and by lead researcher during telephone call for recruitment).

Phase II. Pilot Population: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT.

Inclusion criteria: All patients aged 12-18 years referred to the pan-London long COVID MDT with English of a standard adequate to participate in a group intervention.

Exclusion criteria: No objective evidence of SARS-CoV-2 infection e.g., positive PCR testing or antibodies. Significant neurodevelopmental difficulties (severe autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), global intellectual disability) and/or high psychiatric risk e.g., suicidality, severe emotional or behavioral dysregulation precluding participation in group intervention (PI screened during the MDT discussion and by lead researcher during telephone call for recruitment).

Process: Informed consent or assent will be obtained from all CYP, and parental consent obtained for CYP under 16 years. Parents will be given access to all resources, although the intervention will be targeted towards the CYP.

Each CYP will complete a screening assessment for suitability for the trial. Once a potential participant has consented to take part they will have a Cardio-Pulmonary Exercise Test (CPET) test, lung function, 1:1 breathing pattern assessment by a respiratory physiotherapist and set up with a FitBit monitor before randomisation.

Each Fitbit will be set up by the lead researcher to a new outlook account linked to the participant number. The research team will be able to download data on daily step counts, daily distance travelled, daily stairs climbed, sedentary minutes, low, moderate and vigorous activity minutes, sleep hours, and wear time. The Fitbit will be synced to the patient's mobile phone in clinic so they can review their daily data as well. The Fitbit account will be set up with a generic date of birth, weight, and height so not to identify the patient.

CYP will be randomised (using a block randomisation approach) to receive either standard treatment or standard treatment plus intervention.

Standard treatment consists of virtual MDT discussion with referrer and advice signposting into local services for specific issues. They are sent leaflets and info on online videos (webinars) and directed to standardised information on the Your COVID Recovery Website If a patient is severely affected enough to be seen face to face, they are offered an interdisciplinary consultation, and tailored input from PT, occupational therapy (OT) and psychological services.

Access to bite size videos and leaflets and other standardised information covering the following topics: sleep, pacing, activity management, school reintegration, managing friendships, eating well and emotional wellbeing. Young people are invited to a single virtual group Q\&A session to bring any queries after watching the videos/ webinars.

The leaflets have and online sessions have been developed by professionals from the Evelina, Great Ormond Street Hospital, Imperial, University College London Hospital, and the Whittington. Additional information is being developed in online video/ webinar form as the services evolve. The bite size videos/ webinars and live sessions are delivered by a clinical psychologist, a dietician, specialist nurse, occupational therapist and physiotherapist. More complex or severely affected patients will receive one to one treatment with members of the MDT as required.

Intervention

Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention:

  • Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment
  • Identifying the connections between body and mind to address anxiety and breathlessness
  • Coping skills for managing anxiety using principles from narrative therapy and mindfulness
  • Online materials to improve self-efficacy with home practice
  • Social connection with other CYP for peer support, and resource sharing
  • Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems.
02

Conditions studied

  • Post-COVID-19 Syndrome
  • Anxiety
  • Breathlessness

Keywords

  • Teenager
  • Adolescent
03

In context

Post-Acute COVID-19 Syndrome

520 studies on the registry are indexed under Post-Acute COVID-19 Syndrome; 186 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 361 interventional studies indexed under Post-Acute COVID-19 Syndrome.

Browse Post-Acute COVID-19 Syndrome studies →

Lead sponsor

Royal Brompton & Harefield NHS Foundation Trust is the lead sponsor of 137 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All patients aged 12-18 years referred to the pan-London long COVID MDT with English of a standard adequate to participate in a group intervention.

Exclusion criteria

Exclusion Criteria:

  • No objective evidence of SARS-CoV-2 infection e.g., positive PCR testing or antibodies. Significant neurodevelopmental difficulties (severe autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), global intellectual disability) and/or high psychiatric risk e.g., suicidality, severe emotional or behavioural dysregulation precluding participation in group intervention (PI screened during the MDT discussion and by lead researcher during telephone call for recruitment).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Standard treatment

    Standard treatment consists of virtual MDT discussion with referrer and advice signposting into local services for specific issues. If a patient is severely affected enough to be seen face to face, they are offered an interdisciplinary consultation, and tailored input from PT OT and psychological services. Access to standardised information covering the following topics: sleep, pacing, activity management, school reintegration, managing friendships, eating well and emotional wellbeing. More complex or severely affected patients will receive one to one treatment with members of the MDT as required.

    Behavioral: Psychology interventions

  • Experimental
    Intervention

    As above standard intervention plus the new co-designed intervention. Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention: * Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment * Identifying the connections between body and mind to address anxiety and breathlessness * Coping skills for managing anxiety using principles from narrative therapy and mindfulness * Online materials to improve self-efficacy with home practice * Social connection with other CYP for peer support, and resource sharing * Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems.

    Behavioral: Psychology interventions

Interventions

  • BehavioralPsychology interventions

    Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention: * Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment * Identifying the connections between body and mind to address anxiety and breathlessness * Coping skills for managing anxiety using principles from narrative therapy and mindfulness * Online materials to improve self-efficacy with home practice * Social connection with other CYP for peer support, and resource sharing * Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems.

    Also known as: breathing pattern retraining

06

What researchers measure

Primary outcomes

  1. Impact score of Strength and Difficulties (SDQ) questionnaire

    25 item questionnaire comprising of 5 scales of 5 items

    Time frame: Through study completion, an average of 24 weeks

Secondary outcomes

  1. Revised Childhood Anxiety and Depression Scale (RCADS) questionnaire

    The revised Child Anxiety and Depression Scale is a 47 item youth self reported questionnaire with subscales

    Time frame: Through study completion, an average of 24 weeks

  2. EQ-5D-Y

    The EQ-5D-Y descriptive system comprises of the five dimensions: mobility, looking after myself, doing usual activities, having pain or discomfort and feeling worried/ sad/ unhappy

    Time frame: Through study completion, an average of 24 weeks

  3. SF-36 Quality of Life

    36 item health survey - self reported quality of life measure

    Time frame: Through study completion, an average of 24 weeks

  4. 11 item Chandler Fatigue Questionnaire

    11 item questionnaire is divided into two components, one that measures physical fatigue and on that measures mental fatigue

    Time frame: Through study completion, an average of 24 weeks

  5. Visual Analogue Scale (VAS) Pain scale

    0-10 visual analogue scale of self reported pain

    Time frame: Through study completion, an average of 24 weeks

  6. FitBit Activity monitoring

    Daily step count, daily distance travelled, daily stairs climbed, sedentary minutes, low, moderate and vigorous activity minutes, sleep hours and wear time

    Time frame: Through study completion, an average of 24 weeks

  7. Physiotherapy assessment of dysfunctional breathing

    Multi-dimensional physiotherapy assessment of breathing pattern

    Time frame: Through study completion, an average of 24 weeks

  8. Qualitative feedback

    concurrent and retrospective feedback on the standard and new intervention

    Time frame: Through study completion, an average of 24 weeks

07

Study locations

1 of 1 sites recruiting
  • The Royal Brompton Hospital part of Guys and St Thomas' NHS Foundation Trust
    London, Chelsea SW3 6NP, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — All data will be handled in accordance with the Data Protection Act (2018), National Health Service (NHS) Caldecott Principles, The United Kingdom Policy Framework for Health and Social Care Research, and the condition of the Research Ethics Committee (REC) approval. The Case Report Forms (CRFs) will not bear the subject's name or other personal identifiable data. The subject's study Identification Number (ID) will be used for identification. No data will be shared with any external organisation without appropriate consent and data sharing agreement in place, as applicable.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05705154
Lead sponsor
Royal Brompton & Harefield NHS Foundation Trust
Collaborators
Guy's and St Thomas' NHS Foundation Trust, University College London Hospitals
Responsible party
Sponsor
First posted
Jan 30, 2023
Start date
Apr 30, 2023
Primary completion
Mar 30, 2024 (estimated)
Completion
Mar 30, 2024 (estimated)
Last update
Sep 8, 2023

Study contacts

Samatha Sonnappa, MD PhD
Contact
s.sonnappa@rbht.nhs.uk
02073528121
Ira Jakupovic
Contact
i.jakupovic@rbht.nhs.uk
02073518109

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion